Prolonged therapies can turn cancer into chronic disease

The Wall Street Journal reports that two new studies suggest that the prolonged use of cancer medication helped stunt the progress of the disease, a shift from the scheduled courses of treatment typically delivered to patients.

According to the Journal, both studies show “how cancer is often becoming a chronic disease.” Regarding the drug Rituxan, one study suggests that it cuts the risk of cancer returning in certain lymphoma patients by half when used as a maintenance treatment for two years.